The major part of
clinical studies evaluating the efficacy of probiotics in veterinary patients relates to the gastrointestinal system, particularly diarrhea cases.
A search of Pubmed [a data base containing all medical journal articles] for platelet rich plasma yields 6,811 articles, but less than 20 are
clinical studies evaluating patient outcomes for orthopedic sports medicine conditions.
Techniques Functional imaging of the interaction between gut microbiota and the human host: A proof - of - concept
clinical study evaluating novel use for 18F - FDG PET - CT.
Not exact matches
Researchers in the Mid-Atlantic Mental Illness Research, Education and
Clinical Center at the W.G. (Bill) Hefner Veterans Affairs Medical Center in Salisbury, N.C.,
evaluated 45 U.S. veterans who volunteered to participate in the
study.
«Complex models are needed to effectively
evaluate PMed
study designs, and this proof - of - concept trial validates the dog with cancer as a model for
clinical evaluation of novel PMed approaches,» said Dr. Melissa Paoloni, the
study's lead author and former director of the COTC.
As it matures, the authors wrote, it is moving «from laboratory - based experimental
studies in model systems to a mature discipline that is yielding products that are being
evaluated and used in the
clinical domain.
The discovery of an unexpected biochemical link within tumor cells should lead to
clinical trials for experimental drug treatments that indirectly target myc and that already are being
evaluated in human
studies, the researchers said.
Of the 10 patients enrolled in the
study — a
clinical trial designed to
evaluate safety and feasibility — none of the participants experienced any dangerous side effects and one patient's disease remained stable after 18 months.
«The idea behind this
study was to re-evaluate the bar that was previously established for
evaluating a person's immune response to influenza vaccines,» said the
study's principal investigator Matthew J. Memoli, M.D., director of the
Clinical Studies Unit in NIAID's Laboratory of Infectious Diseases.
The scientists next plan to
evaluate the precise roles of the five genes and to validate the accuracy of their diagnostic assay in a prospective
clinical study.
Researchers at The Royal Manchester Children's Hospital and The University of Manchester have recruited the first child into a new
study, which aims to
evaluate the
clinical effectiveness of a treatment developed in Manchester.
Patients who go to the emergency room (ER) with chest pain often receive unnecessary tests to
evaluate whether they are having a heart attack, a practice that provides no
clinical benefit and adds hundreds of dollars in health - care costs, according to a new
study from researchers at Washington University School of Medicine in St. Louis.
The data obtained from this
study provide a basis for more rapid, cost - effective
clinical trials to
evaluate new influenza drugs or to determine the efficacy of candidate vaccines for both seasonal and pandemic influenza.
The
study, published in the Journal of
Clinical Oncology,
evaluated 46,237 women who continued to attend annual multimodal screening following the first screen.
Dr. El Khoudary and her team
evaluated clinical data, including blood samples and heart CT scans, on 456 women from Pittsburgh and Chicago enrolled in the
Study of Women's Health Across the Nation (SWAN).
To
evaluate the device, the research team collected and
studied 350
clinical semen specimens at the MGH Fertility Center.
Case No. 18 states that a
study in which a healthy volunteer undergoes MRI brain imaging while performing a working memory test is now a
clinical trial because the effect being
evaluated — brain function — is a health - related outcome.
The recent
study, published in the journal Archives of
Clinical Neuropsychology, focuses on using a simple test of visual flicker to
evaluate an individual's level of executive cognitive abilities, such as shifting attention between different tasks, planning or organizing and problem solving.
40 RR - MS patients participated in this
study, all of whom were receiving regular drug therapy and were being
evaluated for disease progression through
clinical examination.
They designed a pilot
clinical study in IBS to
evaluate the effect of a substance that blocks the histamine 1 receptor on the nerves, so that the sensitivity of TRPV1 no longer increases.
An HIV - 1 version of the promising vaccine regimen is now being
evaluated in an ongoing Phase 1 / 2a international
clinical study.
The USPSTF based its recommendations on a meta - analysis of 136
clinical trials, observational
studies and a systematic review
evaluating the effects of supplementation on fracture and cancer risk.
Based on these pre-
clinical data, the HIV - 1 version of this vaccine regimen is now being
evaluated in an ongoing Phase 1 / 2a international
clinical study sponsored by Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
The
study, «A Multi-Center
Clinical Trial to
Evaluate the Effectiveness of Intermittent Hypoxia Therapy in Individuals with Spinal Cord Injury (SCI),» is being conducted by an experienced team of scientists and clinicians at three leading SCI rehabilitation institutions: Shirley Ryan AbilityLab (lead investigator, William Zev Rymer, MD, PhD), Kessler Foundation (Gail Forrest, PhD; Steven Kirshblum, MD), and the University of Miami (Monica A. Perez, PT, PhD).
SEATTLE, WA and DURHAM, NC — The HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) today announced the initiation of HVTN 704 / HPTN 085, also known as Antibody Mediated Prevention (AMP) or the AMP
Study, a Phase 2b
clinical trial to
evaluate the safety and efficacy of VRC01, a broadly neutralizing monoclonal antibody (bnAb).
A Phase 1b / 2 Open - Label
Study to
Evaluate Safety,
Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies
Ultimately, this will provide for current and future
studies such as those that
evaluate the correlation of biological markers with
clinical variables and cancer outcomes, as well as those that identify interactions among biological markers.
The Biomarkers for Spinal Muscular Atrophy (BforSMA)
clinical trial is a current pilot
study looking to identify potential biomarkers (measures) that can be used to
evaluate SMA disease severity and future treatments.
«Investigational» means that the drug is still being
evaluated in
clinical studies, and has not yet been approved for use by doctors in their everyday practice.
In the
study, the researchers identified 44,144 patients enrolled in
clinical trials
evaluating hematologic malignancies submitted to the FDA in support of approval of new or supplemental indications from 2005 to 2015.
A
clinical trial (or
clinical research) is a research
study to
evaluate a new drug or treatment.
The first
clinical trial was a safety
study in Australia, followed by an ongoing efficacy
study in Peru to
evaluate the ability to treat patients with malaria.
This is the first
study to
evaluate the safety and
clinical activity of the combination of oral pazopanib, intravenous or oral irinotecan, and oral temozolomide in pediatric and young adult patients with relapsed or refractory sarcomas.
The results from this cohort will help us
evaluate what is the optimal dose for a future, larger
clinical study.
In the largest analysis of PD - 1 blockade in mucosal melanoma to date, patients treated in
clinical studies with either nivolumab monotherapy or nivolumab combined with ipilimumab were
evaluated in a pooled analysis.
Research You will have access to appropriate
clinical studies to
evaluate new methods for the early detection of cancer, cancer prevention, cancer treatment, and genetic testing.
Paris, France, April 3, 2018, 5.35 pm CET — GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA - PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced topline results from the REVERSE Phase III
clinical trial
evaluating the safety and efficacy of a single intravitreal injection of GS010 (rAAV2 / 2 - ND 4) in 37 subjects whose visual loss due to 11778 - ND4 Leber Hereditary Optic Neuropathy (LHON) commenced between 6 and 12 months prior to
study treatment.
Evaluating the efficacy of repurposed small molecule inhibitors in treating filariasis using preclinical and
clinical studies
Together, our data suggest that
clinical studies may be warranted to
evaluate the therapeutic potential of ABL allosteric inhibitors and to determine whether combination therapies that incorporate these compounds are effective in treating metastatic breast cancer.
Our group focuses on developing pharmaceutical and immunological strategies to reduce HIV - 1 persistence, and on
evaluating such interventions in
clinical studies.
The RETAIN
Study is a clinical research study evaluating a protein called alpha - 1 antitrypsin (AAT) in recently diagnosed type 1 diabetes pati
Study is a
clinical research
study evaluating a protein called alpha - 1 antitrypsin (AAT) in recently diagnosed type 1 diabetes pati
study evaluating a protein called alpha - 1 antitrypsin (AAT) in recently diagnosed type 1 diabetes patients.
This recommendation was rooted in an earlier observation by Williams et al, 19 based on both priority scores and funding rates, that
clinical grant applications do not fare as well in the review process when
evaluated by
study sections reviewing relatively few
clinical applications.
However, when 50 children were
evaluated with the Autism Diagnostic Interview — Revised 35 and the Autism Diagnostic Observation Schedule — Generic, 36 94 % met criteria for ASD on both instruments, and 100 % met criteria on at least 1 instrument.37 Record - review validation
studies conducted by the investigators demonstrate that the predictors of valid ASD diagnoses were having more than 2 diagnoses in the medical record.38 Most influenza infections in our
study were determined from International Classification of Diseases, Ninth Revision,
Clinical Modification diagnostic codes rather than serologic evidence.
Armed with this knowledge, and the results of an initial feasibility
study, the Dream Team will conduct a
clinical trial to
evaluate if personalized therapy, based on the genetic profile of each individual patient's cancer, improves outcomes.
Recently, Dr. Wapner led a multicenter
study evaluating the accuracy, efficacy, and
clinical advantages of prenatal diagnosis using microarray analysis.
In 1996, in response to these concerns, Varmus, then director of NIH, impaneled a group of experienced
clinical investigators and academic health center administrators to make recommendations that might guide the NIH toward policy changes to alleviate the concerns in the clinical research community.14 Several of the panel's recommendations have been implemented, including increased support of the General Clinical Research Center budget, expanded support of training in clinical research, and the establishment of NIH - sponsored educational debt relief programs for clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be evaluated by study sections in which at least half the grant applications involve patient - oriented r
clinical investigators and academic health center administrators to make recommendations that might guide the NIH toward policy changes to alleviate the concerns in the
clinical research community.14 Several of the panel's recommendations have been implemented, including increased support of the General Clinical Research Center budget, expanded support of training in clinical research, and the establishment of NIH - sponsored educational debt relief programs for clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be evaluated by study sections in which at least half the grant applications involve patient - oriented r
clinical research community.14 Several of the panel's recommendations have been implemented, including increased support of the General
Clinical Research Center budget, expanded support of training in clinical research, and the establishment of NIH - sponsored educational debt relief programs for clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be evaluated by study sections in which at least half the grant applications involve patient - oriented r
Clinical Research Center budget, expanded support of training in
clinical research, and the establishment of NIH - sponsored educational debt relief programs for clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be evaluated by study sections in which at least half the grant applications involve patient - oriented r
clinical research, and the establishment of NIH - sponsored educational debt relief programs for
clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be evaluated by study sections in which at least half the grant applications involve patient - oriented r
clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented grant applications would be
evaluated by
study sections in which at least half the grant applications involve patient - oriented research.
Priority will be given to
studies that
evaluate combinations of agents that induce immune deviation and / or regulation, produce effector cell depletion or exhaustion, to achieve durable
clinical remission of disease.
«This
study allowed us to
evaluate the protective efficacy of several prime - boost vaccine combinations, and these data will help guide the advancement of the most promising candidates into
clinical trials,» noted lead author Dr. Dan Barouch of Beth Israel Deaconess Medical Center at Harvard Medical School and the Ragon Institute of MGH, MIT, and Harvard.
The purpose of this
study is to
evaluate the safety, pharmacokinetics, pharmacodynamics and
clinical activity of AG - 120 in advanced hematologic malignancies that harbor an IDH1 mutation.
The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational
clinical study to comprehensively
evaluate cohorts of significant interest using advanced imaging, biologic sampling and
clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.